212 related articles for article (PubMed ID: 2434139)
1. Inhibition of lymphoid cell growth by adenine ribonucleotide accumulation. The role of phosphoribosylpyrophosphate-depletion induced pyrimidine starvation.
van der Kraan PM; van Zandvoort PM; De Abreu RA; van Baal JM; Bakkeren JA
Biochim Biophys Acta; 1987 Feb; 927(2):213-21. PubMed ID: 2434139
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
3. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
5. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
6. Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.
Snyder FF; Dyer C; Seegmiller JE; Goldblum RM; Mills GC; Schmalstieg FC
J Inherit Metab Dis; 1988; 11(2):174-83. PubMed ID: 2459496
[TBL] [Abstract][Full Text] [Related]
7. Adenine aminohydrolase: occurrence and possible significance in trypanosomid flagellates.
Kidder GW; Nolan LL
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3670-2. PubMed ID: 291031
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts.
Snyder FF; Hershfield MS; Seegmiller JE
Cancer Res; 1978 Aug; 38(8):2357-62. PubMed ID: 667833
[TBL] [Abstract][Full Text] [Related]
10. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
11. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
Faltynek CR
Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
Hunt SW; Hoffee PA
J Biol Chem; 1982 Dec; 257(23):14239-44. PubMed ID: 6815190
[TBL] [Abstract][Full Text] [Related]
13. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
15. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
Kefford RF; Fox RM
Cancer Chemother Pharmacol; 1983; 10(2):73-8. PubMed ID: 6600985
[No Abstract] [Full Text] [Related]
16. Levels of adenosine deaminase AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors.
Fishbein WN; Davis JI; Winkert JW; Strong DM
Biochem Med; 1981 Dec; 26(3):377-86. PubMed ID: 6277304
[No Abstract] [Full Text] [Related]
17. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
Franco R; Hoyle CH; Centelles JJ; Burnstock G
Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
[TBL] [Abstract][Full Text] [Related]
18. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
19. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
Schramm VL; Baker DC
Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
